Jason Blessing was appointed Director of Evolv Technologies Holdings, Inc., effective November 6, 2026. As of November 10, 2026, Evolv Technologies Holdings, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on November 9, 2026, naming 2 appointments (Form 8-K, November 9, 2026).
Evolv Technologies Holdings, Inc. named a new Director on Nov 9. 30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Evolv Technologies Holdings, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Evolv Technologies Holdings, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-11-09. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Evolv Technologies Holdings, Inc. files it.
Also on the record for Evolv Technologies Holdings, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| July 28, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 7.5% of the class | 5%+ stakes | Source |
| April 17, 2026 | Stake report, Schedule 13G/A, by General Catalyst Group Management Holdings GP, LLC | — | 5%+ stakes | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| October 30, 2025 | Stake report, Schedule 13G/A, by The Vanguard Group | 6.97% of the class | 5%+ stakes | Source |
| September 22, 2025 | Stake report, Schedule 13G/A, by Gates Frontier, LLC | 1.4% of the class | 5%+ stakes | Source |
| August 22, 2025 | Stake report, Schedule 13D/A, by Data Collective IV, L.P. | 4.7% of the class | 5%+ stakes | Source |
| August 19, 2025 | Stake report, Schedule 13D/A, by Stoic Point Capital Management LLC | 3.1% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Evolv Technologies Holdings, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Evolv Technologies Holdings, Inc. and the records around it.
Evolv Technologies Holdings, Inc. elsewhere on the record
- 5%+ stake filings Jul 2026
- Who owns it
Companies that share a holder
- Gates Frontier, LLC also filed stake reports on 1 other company: Lyell Immunopharma, Inc. (Aug 2025)
- General Catalyst Group Management Holdings GP, LLC also filed stake reports on 1 other company: Circle Internet Group, Inc. (Feb 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
Watch Evolv Technologies Holdings, Inc.
Get an email when Evolv Technologies Holdings, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Evolv Technologies Holdings, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Evolv Technologies Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Evolv Technologies Holdings, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-11-09 | In | Director | 2026-11-06 | 8-K, 2026-11-09 | |
| 2026-11-09 | In | 8-K, 2026-11-09 |
Who leads Evolv Technologies Holdings, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Director: Jason Blessing, appointed, effective 2026-11-06 (filed 2026-11-09).
New leaders reset buying decisions — get the Full Report on Evolv Technologies Holdings, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Director at Evolv Technologies Holdings, Inc., with the record behind each one.
Find candidates like Director at Evolv Technologies Holdings, Inc.Every change, in the filing's words
Appointed: Jason Blessing, Director, effective 2026-11-06
On November 6, 2026, the Board of Directors (the "Board") of Evolv Technologies Holdings, Inc. (the "Company") appointed Jason Blessing, age 55, to the Board, effective November 6, 2026, to serve as a Class III director until the Company's 2027 annual meeting of stockholders.
Appointed: Jason Blessing
The Board also appointed Mr. Blessing to the Audit Committee and the Nominating and Corporate Governance Committee.
- In approving the appointment, the Board concluded that Mr. Blessing satisfies the independence requirements of Rule 10A-3 under the Securities Exchange Act of 1934, as amended, and the applicable rules of The Nasdaq Stock Market LLC, including the requirements applicable to audit committee membership.
- The Board also determined that Mr. Blessing is an "audit committee financial expert" as that term is defined by applicable Securities and Exchange Commission regulations.
- Jason Blessing has a strong track record as an executive and operator with more than 30 years of experience, including service as a public company chief executive officer and director.
- Mr. Blessing currently serves as Executive Chair of Mosai and as a director of eClinical Solutions and Parsec Automation, both privately held software companies, and as an advisor to the CEO of AptEdge.
- His experience includes leading go-to-market, product and technology organizations.
- From May 2018 to September 2024, Mr. Blessing served as President and Chief Executive Officer of Model N, Inc. (formerly NYSE: MODN), and served as a director of Model N from May 2018 until August 2026.
- From January 2013 to December 2017, Mr. Blessing served as President, Chief Executive Officer and a director of Plex Systems, now part of Rockwell Automation.
Tools for this story
Each opens in a new tab, filled in for Evolv Technologies Holdings, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.